Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSC-EXOs Nasal Spray for Childhood Autism
NCT07243561Phase 2Recruiting
- Sponsor
- Dongfang People's Hospital
- Start
- Sep 2025
- Primary completion
- Oct 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell-derived exosomes in Autism Spectrum Disorder (ASD), sponsored by Dongfang People's Hospital. Started Sep 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell-derived exosomes
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT07243561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07243561.